CNAT - Conatus Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-10.1. This is a potential upside of $-10.1 (0%) from yesterday's end of day stock price of $0.

Conatus Pharmaceuticals's activity chart (see below) currently has 12 price targets and 7 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 208.5 days.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 22-Mar-2019. First documented stock forecast 22-Sep-2015.

Best performing analysts who are covering CNAT - Conatus Pharmaceuticals:

Ed Arce Stephen Willey

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$8

$7.44 (1328.57%)

$8

5 years 8 months 4 days ago
(22-Mar-2019)

7/7 (100%)

$-4.8 (-37.50%)

216

Buy

$4

$3.44 (614.29%)

5 years 11 months 20 days ago
(06-Dec-2018)

1/1 (100%)

$-15.4 (-79.38%)

201

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CNAT (Conatus Pharmaceuticals) average time for price targets to be met?

On average it took 208.5 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on CNAT (Conatus Pharmaceuticals) with a proven track record?

ED ARCE

Which analyst has the current lower performing score on CNAT (Conatus Pharmaceuticals) with a proven track record?

STEPHEN WILLEY

Which analyst has the most public recommendations on CNAT (Conatus Pharmaceuticals)?

Ed Arce works at HC WAINWRIGHT and has 10 price targets and 8 ratings on CNAT

Which analyst is the currently most bullish on CNAT (Conatus Pharmaceuticals)?

Ed Arce with highest potential upside - $7.44

Which analyst is the currently most reserved on CNAT (Conatus Pharmaceuticals)?

Stephen Willey with lowest potential downside - $3.44

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?